Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Luis Felipe Calvo-Torres"'
Autor:
Luis Felipe Calvo-Torres, Felipe Vera-Polania, Juan D. Ayala-Torres, Juan M. Solano-Atehortua, Jorge E. Machado-Alba
Publikováno v:
Acta Neurológica Colombiana, Vol 37, Iss 2 (2021)
OBJETIVOS: Determinar el patrón de prescripción de riluzol y las variables asociadas a su utilización en una población de pacientes con enfermedad de neurona motora afiliados al Sistema General de Seguridad Social en Salud de Colombia (SGSSS) e
Externí odkaz:
https://doaj.org/article/d0a466199591423f8280de2e8e8378c9
Autor:
Jorge Enrique Machado-Alba, Luis Felipe Calvo-Torres, Andrés Gaviria-Mendoza, Juan Daniel Castrillón-Spitia
Publikováno v:
Biomédica: revista del Instituto Nacional de Salud, Vol 38, Iss 3, Pp 417-426 (2018)
Introduction: Parkinson’s disease, whose prevalence in Colombia is 4.7 per 1,000 inhabitants, is a public health problem and a therapeutic challenge for health professionals. Objective: To determine the prescribing patterns of antiparkinson drugs a
Externí odkaz:
https://doaj.org/article/270e2fcfae1443a6ac17480deb498ebb
Autor:
Aníbal Valencia Vásquez, Andrés Gaviria Mendoza, Juan Daniel Ayala Torres, Luis Felipe Calvo Torres, Jorge Enrique Machado-Alba
Publikováno v:
Revista de Neurología. 76:1
Autor:
Mauricio Montoya Cañón, Oscar Barbosa Gantiva, Luis Felipe Calvo Torres, Vanesa Hincapié, José Willian Martínez, Raúl Eduardo Aristizabal, Luis Alfonso Valencia
Publikováno v:
Revista Médicas UIS. 28:273-280
Introduction: Trauma is a public health problem in Colombia and is the first cause of death in young people with an incidence rate of 331.99 cases per 100 000 inhabitants, of which approximately 30% die in the intensive care unit. These patients acco
Autor:
Jorge Enrique, Machado-Alba, Luis Felipe, Calvo-Torres, Andrés, Gaviria-Mendoza, César, Augusto MejíA-Vélez
Publikováno v:
Musclenerve. 56(6)
We determined the pyridostigmine prescription pattern in a population of patients with myasthenia gravis (MG). A descriptive cross-sectional study was conducted by using a prescription database of 3.5 million individuals from which patients who had b